• LAST PRICE
    2.0750
  • TODAY'S CHANGE (%)
    Trending Down-0.0150 (-0.7177%)
  • Bid / Lots
    2.0700/ 2
  • Ask / Lots
    2.0800/ 2
  • Open / Previous Close
    2.0600 / 2.0900
  • Day Range
    Low 2.0600
    High 2.1100
  • 52 Week Range
    Low 1.6500
    High 15.1000
  • Volume
    19,677
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 2.09
TimeVolumeBVS
09:32 ET5812.07
09:33 ET1002.06
09:35 ET3872.07
09:37 ET3562.08
09:44 ET1002.09
09:46 ET3002.085
09:50 ET1002.11
09:53 ET1002.1
10:11 ET5342.11
10:15 ET4092.09
10:20 ET2002.09
10:22 ET1002.1
10:24 ET4842.09
10:31 ET3002.09
10:47 ET1002.08
11:09 ET33002.0788
11:14 ET1002.08
11:21 ET35002.0725
11:23 ET2002.075
11:25 ET2002.075
11:27 ET1002.075
11:34 ET1002.075
11:38 ET8252.075
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesBVS
Bioventus Inc
162.5M
-1.0x
---
United StatesWGS
GeneDx Holdings Corp
147.4M
-0.4x
---
United StatesSDC
SmileDirectClub Inc
207.2M
-0.7x
---
United StatesTCMD
Tactile Systems Technology Inc
257.6M
-8.5x
---
United StatesFUJIY
Fujifilm Holdings Corp
27.5B
13.2x
+12.26%
United StatesRVP
Retractable Technologies Inc
64.2M
2.2x
---
As of 2023-01-27

Company Information

Bioventus Inc. is a medical device company. The Company is focused on developing and commercializing clinically differentiated and minimally invasive treatments that engage and enhance the body's natural healing process. Its portfolio of products is grouped into three verticals: Pain Treatments, Surgical Solutions and Restorative Therapies. Its Pain Treatments consist of non-surgical joint pain injection therapies as well as peripheral nerve stimulation (PNS) products to help the patient get back to their normal activities. Its Surgical Solutions consists of bone graft substitutes (BGS) to fuse and grow bones and ultrasonic medical devices used for precise bone sculpting, removal of tumors and tissue debridement, in various surgeries, including spine and neurosurgery. Its Restorative Therapies consist of an ultrasonic bone healing system for fracture care, skin allografts and products used to support healing of chronic wounds as well as advanced rehabilitation devices.

Contact Information

Headquarters
4721 EMPEROR BOULEVARD, SUITE 100DURHAM, NC, United States 27703
Phone
919-474-6700
Fax
302-655-5049

Executives

Non-Executive Independent Chairman of the Board
William Hawkins
Chief Executive Officer, Director
Kenneth Reali
Senior Vice President, Chief Financial Officer and Principal Accounting Officer
Mark Singleton
Senior Vice President, Chief Scientific Officer
Alessandra Pavesio
Senior Vice President, Chief Compliance Officer
Katrina Church

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$162.5M
Revenue (TTM)
$516.7M
Shares Outstanding
77.7M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$-2.07
Book Value
$6.09
P/E Ratio
-1.0x
Price/Sales (TTM)
0.3
Price/Cash Flow (TTM)
---
Operating Margin
-44.28%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.